<DOC>
	<DOCNO>NCT01766882</DOCNO>
	<brief_summary>The purpose study conduct pilot , randomize trial stable HD patient evaluate effect gradual , step-wise reduction post-hemodialysis target weight , combine diligent dietary sodium restriction reduction dialysate sodium exposure hydration/volume status blood pressure ( BP ) control .</brief_summary>
	<brief_title>Volume , Sodium Blood Pressure Management HD</brief_title>
	<detailed_description>Fluid-weight management critical dialysis patient 1 , 2 . Previous clinical trial comprehensively address application strategy combine sodium restriction progressive , gradual challenge post dialysis target weight BP fluid-weight management hemodialysis ( HD ) . The investigator postulate protocolized , stepwise gradual challenge post-hemodialysis target weight combine diligent dietary sodium restriction &lt; 2000mg sodium/day , lead well hydration/volume status BP control HD patient . A randomized , two parallel arm trial ( n=40 ) among HD patient propose , compare comprehensive strategy one group versus 'usual ' HD volume/hydration BP management control group . The two primary outcome change volume/hydration status ( assessed bioelectrical impedance analysis-BIA ) change BP ( pre-dialysis in-center reading , home self-monitored reading well 44-hour interdialytic BP ) . Secondary outcome include change target post-dialysis weight , slope on-line relative plasma volume monitoring ( use Crit-line monitor ) , utilization change , , antihypertensive regimen , change interdialytic weight gain , objectively assessed salt-appetite , thirst score , frequency intradialytic hypotension , cramps duration post-dialysis fatigue recovery , time achievement dry weight laboratory parameter ( hemoglobin , albumin , brain natriuretic peptide-BNP , aldosterone hsCRP ) . The trial 14-weeks duration involve comprehensive assessment study parameter baseline , middle end trial . It anticipate trial lead development simple practical approach volume BP control HD patient subsequently need study large scale , i.e. , large , multicenter study hard endpoint death hospitalization .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>Stable adult HD patient ( age 1885 year ) Usual incenter predialysis systolic blood pressure ≥130mmHg . For purpose mean predialysis sit blood pressure past one month prior randomization apply evaluation inclusion criterion . Able willing adhere study protocol Recent acute illness ( ≤1month ) Recent hospitalization ( ≤1month ) Any psychological condition could interfere compliance study protocol . Amputation low limb ( due interference electric current BIA measurement ) Pacemaker , defibrillator , implantable pump , artificial joint , pin , plat type metal object body ( dental filling ) , presence interfere appropriate measurement . In patient consideration give calfBIA measurement total body , discretion investigator . Use investigational product device within 30 day prior screen , requirement investigational agent prior completion schedule study assessment . Pregnancy lactation ( pregnancy test apply patient reproductive age range ) . Any condition , view PI , place subject high risk poor treatment compliance completing study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Hemodialysis</keyword>
	<keyword>Blood Pressure</keyword>
	<keyword>Hydration Status</keyword>
	<keyword>Low-sodium diet</keyword>
</DOC>